Craft

AN2 Therapeutics

Stock Price

$1.1

2024-10-29

Market Capitalization

$33.1 M

2024-10-29

AN2 Therapeutics Summary

Company Summary

Overview
AN2 Therapeutics is a health biopharmaceutical company. It focuses on bringing biomedical and drug development expertise to treat rare, chronic, and serious infectious diseases. The company also offers a drug discovery platform Boron which is based on the use of boron chemistry for research and development initiatives.
Type
Public
Status
Active
Founded
2019
HQ
Menlo Park, CA, US | view all locations
Website
https://www.an2therapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Eric Easom

    Eric Easom, Co-Founder, President & CEO

  • George H. Talbot

    George H. Talbot, Co-Founder & Senior Clinical Advisor

    • Joseph S. Zakrzewski

      Joseph S. Zakrzewski, Co-Founder, and Chair of the Board of Directors

    • Sanjay Chanda

      Sanjay Chanda, Chief Development Officer

    LocationsView all

    1 location detected

    • Menlo Park, CA HQ

      United States

      1800 El Camino Real UNIT C

    AN2 Therapeutics Financials

    Summary Financials

    Net income (Q1, 2026)
    ($10.0M)
    Cash (Q1, 2026)
    $53.5M
    EBIT (Q1, 2026)
    ($10.6M)

    Footer menu